BrainsWay to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021
March 11, 2021 07:00 ET
|
BrainsWay
CRESSKILL, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference
March 08, 2021 08:00 ET
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, March 08, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of...
BrainsWay Hosting Key Opinion Leader Call on Deep Transcranial Magnetic Stimulation for Treating Psychiatric Disorders
November 17, 2020 07:00 ET
|
BrainsWay
CRESSKILL, N.J. and JERUSALEM, Nov. 17, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced, non-invasive treatment of...
BrainsWay Announces Publication of New Real-World OCD Data for its Deep TMS System in Journal of Psychiatric Research
November 11, 2020 07:00 ET
|
Brainsway Ltd.
Additional data on first non-invasive medical device cleared by the FDA for OCD demonstrated that 73% responded positively to Deep TMS, and durability of therapeutic effect was shown Results to...
BrainsWay to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 08, 2020 07:00 ET
|
Brainsway Ltd.
CRESSKILL, N.J. and JERUSALEM, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive...
BrainsWay to Report Second Quarter 2020 Financial Results and Operational Highlights on August 12, 2020
July 29, 2020 07:00 ET
|
Brainsway Ltd.
CRESSKILL, N.J. and JERUSALEM, Israel, July 29, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive...
BrainsWay Announces Shipment of 100th Deep Transcranial Magnetic Stimulation Helmet for the Treatment of Obsessive-Compulsive Disorder
June 24, 2019 07:00 ET
|
Brainsway Ltd.
JERUSALEM and HACKENSACK, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE:BWAY) (BrainsWay” or the “Company”), a commercial stage medical device company focused on the...